CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182

The Quick Take
SHANGHAI, Nov. 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces the clinical data from CT1182 (KJ-C2529), a CD19/CD20-targeting in vivo CAR T-cell product candidate developed on...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Ladera Medical Presents Full FASTEN Results Showing Rapid Hemostasis and a Strong Safety Profile with its Large Bore Closure System
Late-breaking data from 55 TAVR/TAVI patients presented at London Valves 2026. LONDON, Nov. 22, 2026 /PRNewswire/ -- Ladera Medical today announced full…
Local
Major casino operator severs ties with problem gambling group over Kalshi membership - Las Vegas Review-Journal
Business
Procter & Gamble to Increase Factory Shifts Without Humans to Cut Costs
The maker of Pampers and Bounty paper towels operates 15 sites capable of running shifts unattended, with plans to add more in 2027.
Business
The Case of the Idle Assistants
Plus: Can I lie about having kids, and do I have to use my personal phone?
